{
  "title": "Biosimilars Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)",
  "slug": "global-biosimilars-market-industry",
  "industry": "Pharmaceuticals & Therapeutics",
  "parent_industry": "Healthcare (Pharma, Medical Devices, Biotech)",
  "url": "https://www.mordorintelligence.com/industry-reports/global-biosimilars-market-industry",
  "scraped_at": "2026-09-17T17:43:30+07:00",
  "dataset_properties": [
    {
      "@type": "PropertyValue",
      "name": "Market Size (2026)",
      "value": 49.49,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Size (2031)",
      "value": 112.93,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Growth Rate (2026 - 2031)",
      "value": 17.95,
      "unitText": "PERCENT"
    },
    {
      "@type": "PropertyValue",
      "name": "Fastest Growing Market",
      "value": "Asia Pacific"
    },
    {
      "@type": "PropertyValue",
      "name": "Largest Market",
      "value": "Europe"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Concentration",
      "value": "Medium"
    }
  ],
  "faq": [
    {
      "@type": "Question",
      "name": "How big is the Global Biosimilars Market?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The Global Biosimilars Market size is expected to reach USD 49.49 billion in 2026 and grow at a CAGR of 17.95% to reach USD 112.93 billion by 2031."
      }
    },
    {
      "@type": "Question",
      "name": "Which region holds the largest biosimilar market share?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Europe leads with a 36.65 % market share, supported by its early regulatory framework and high adoption rates."
      }
    },
    {
      "@type": "Question",
      "name": "Which is the fastest growing region in  Global Biosimilars Market?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2026-2031)."
      }
    },
    {
      "@type": "Question",
      "name": "Why are monoclonal antibody biosimilars so important?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Monoclonal antibodies command 47.35 % of biosimilar revenue because their reference products are high-cost therapies in oncology and autoimmune diseases, creating strong economic incentives for follow-on versions."
      }
    }
  ],
  "images": [
    "images/global-biosimilars-market-industry-size-image-1776097029817.png",
    "images/global-biosimilars-market-industry_1612261940626_biosimilar_Market__Graph_trend_1.png",
    "images/global-biosimilars-market-industry-Biosimilars-Market-Market-Share-by-Product-Class-2025-1776097259057.png",
    "images/global-biosimilars-market-industry-Biosimilars-Market-Market-Share-by-Manufacturing-Type-2025-1776097275186.png",
    "images/global-biosimilars-market-industry-Biosimilars-Market-CAGR--Growth-Rate-by-Region-2026---2031-1776097760758.png",
    "images/global-biosimilars-market-industry-competitive-landscape-1776097816068.png",
    "images/market-snapshot.png",
    "images/Esomar-25.png",
    "images/GPTW-25-3xl.png",
    "images/global-biosimilars-market-industry-size-image-1776097029817.png"
  ],
  "sections_count": 11
}